From the Journals

Are Children Born Through ART at Higher Risk for Cancer?


 

The results of a large French study comparing the cancer risk in children conceived through assisted reproductive technology (ART) with that of naturally conceived children were published recently in JAMA Network Open. This study is one of the largest to date on this subject: It included 8,526,306 children born in France between 2010 and 2021, of whom 260,236 (3%) were conceived through ART, and followed them up to a median age of 6.7 years.

Motivations for the Study

ART (including artificial insemination, in vitro fertilization [IVF], or intracytoplasmic sperm injection [ICSI] with fresh or frozen embryo transfer) accounts for about 1 in 30 births in France. However, limited and heterogeneous data have suggested an increased risk for certain health disorders, including cancer, among children conceived through ART. Therefore, a large-scale evaluation of cancer risk in these children is important.

No Overall Increase

In all, 9256 children developed cancer, including 292 who were conceived through ART. Thus, this study did not show an increased risk for cancer (of all types combined) in children conceived through ART. Nevertheless, a slight increase in the risk for leukemia was observed in children conceived through IVF or ICSI. The investigators observed approximately one additional case for every 5000 newborns conceived through IVF or ICSI who reached age 10 years.

Epidemiological monitoring should be continued to better evaluate long-term risks and see whether the risk for leukemia is confirmed. If it is, then it will be useful to investigate the mechanisms related to ART techniques or the fertility disorders of parents that could lead to an increased risk for leukemia.

This story was translated from Univadis France, which is part of the Medscape Professional Network, using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. A version of this article appeared on Medscape.com.

Recommended Reading

ASTRO Releases New EBRT Guideline for Symptomatic Bone Mets
MDedge Hematology and Oncology
Exercise Improves Sexual Health in Women With Metastatic Breast Cancer
MDedge Hematology and Oncology
The ASCO Annual Meeting Starts This Week
MDedge Hematology and Oncology
Mailed Outreach for CRC Screening Appeals Across Races and Ethnicities
MDedge Hematology and Oncology
Gene Tests Could Predict if a Drug Will Work for a Patient
MDedge Hematology and Oncology
Bariatric Surgery May Reduce Breast Cancer Risk for Some
MDedge Hematology and Oncology
Colorectal Cancer Is Spiking Among Some Young Americans
MDedge Hematology and Oncology
Red Flags for Early-Onset Colorectal Cancer Identified
MDedge Hematology and Oncology
Young People’s Gut Bacteria May Drive Colorectal Cancer Risk
MDedge Hematology and Oncology
About 20% of Breast Cancer Survivors Gain Excess Weight
MDedge Hematology and Oncology